Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | E7016 |
Synonyms | |
Therapy Description |
E7016 is an inhibitor of PARP1 and PARP2, which results in the accumulation of DNA damage, thereby potentially resulting in increased tumor cell death and increased sensitivity to DNA damaging agents (Mol Cancer Ther 2011;10(11 Suppl):Abstract nr B185, PMID: 19147766). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
E7016 | E-7016 | PARP Inhibitor (Pan) 31 | E7016 is an inhibitor of PARP1 and PARP2, which results in the accumulation of DNA damage, thereby potentially resulting in increased tumor cell death and increased sensitivity to DNA damaging agents (Mol Cancer Ther 2011;10(11 Suppl):Abstract nr B185, PMID: 19147766). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|